Evidence map›Paper›PMID 42515083›Full record

ArticlePathogens (Basel, Switzerland)2026

Long-Term Outcomes After Hepatectomy for Alveolar Echinococcosis in Immunosuppressed Patients.

Djana Rrupa, Christelle Kaiser, Emmanuel Melloul, Emilie Uldry, Nermin Halkic, Guido Beldi, Severin Gloor, Anja Lachenmayer, Gaëtan-Romain Joliat

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pathogens (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Djana RrupaDepartment of Visceral Surgery, Lausanne University Hospital CHUV, University of Lausanne (UNIL), 1011 Lausanne, Switzerland.ORCID 0009-0003-7021-3896
Christelle KaiserDepartment of Visceral Surgery, Lausanne University Hospital CHUV, University of Lausanne (UNIL), 1011 Lausanne, Switzerland.
Emmanuel MelloulDepartment of Visceral Surgery, Lausanne University Hospital CHUV, University of Lausanne (UNIL), 1011 Lausanne, Switzerland.
Emilie UldryDepartment of Visceral Surgery, Lausanne University Hospital CHUV, University of Lausanne (UNIL), 1011 Lausanne, Switzerland.ORCID 0000-0002-2493-0750
Nermin HalkicDepartment of Visceral Surgery, Lausanne University Hospital CHUV, University of Lausanne (UNIL), 1011 Lausanne, Switzerland.
Guido BeldiDepartment of Visceral Surgery and Medicine, Inselspital-Bern University Hospital, University of Bern, 3010 Bern, Switzerland.ORCID 0000-0002-9914-3807
Severin GloorDepartment of Visceral Surgery and Medicine, Inselspital-Bern University Hospital, University of Bern, 3010 Bern, Switzerland.ORCID 0000-0002-9756-9425
Anja LachenmayerDepartment of Visceral Surgery and Medicine, Inselspital-Bern University Hospital, University of Bern, 3010 Bern, Switzerland.ORCID 0000-0002-5879-5737
Gaëtan-Romain JoliatDepartment of Visceral Surgery, Lausanne University Hospital CHUV, University of Lausanne (UNIL), 1011 Lausanne, Switzerland.ORCID 0000-0002-8725-3494

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Long-term outcomes after hepatectomy for alveolar echinococcosis (AE) in immunosuppressed patients remain poorly investigated. This study evaluated recurrence rates and recurrence-free/overall survivals (RFS/OS) after AE resection in immunocompromised and immunocompetent patients. Consecutive patients operated for liver AE in two university hospitals were retrospectively collected (2000-2021). Immunosuppressed patients were defined as patients who had a reduced ability to fight infection due to certain diseases or treatments. 195 patients had hepatectomy for liver AE. Preoperative albendazole was given in 111 cases (57%). Fifty-two patients (27%) were considered immunosuppressed. Patients in the immunosuppressed and immunocompetent cohorts had similar preoperative characteristics. Recurrences occurred in 10 patients (immunosuppressed group: 4, non-immunosuppressed group: 6) within a median follow-up of 58 months (95%CI 48-68). No significant differences in RFS and OS were found between the immunosuppressed and immunocompetent groups (212 vs. 206 months,

Indexed as

EchinococcosisEchinococcosis, HepaticHepatectomyImmunocompromised HostAdultAgedAlbendazoleAnimalsFemaleHumansMaleMiddle AgedRecurrenceRetrospective StudiesTreatment OutcomeAlbendazolealveolar echinococcosisEchinococcus multilocularisimmunosuppressed patientsliver resectionoutcomes

Identifiers

PMID42515083
PMCPMC13414700

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.